Genetic Technologies Ltd (GTG)

0.003
-0.001(-16.67%)
  • Volume:
    2,531,426
  • Bid/Ask:
    0.002/0.003
  • Day's Range:
    0.003 - 0.003

GTG Overview

Prev. Close
0.003
Day's Range
0.003-0.003
Revenue
4.61M
Open
0.003
52 wk Range
0.002-0.006
EPS
-0.001
Volume
2,531,426
Market Cap
27.7M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,609,610
P/E Ratio
-3.00
Beta
0.98
1-Year Change
-40%
Shares Outstanding
9,233,965,143
Next Earnings Date
28 Feb 2023
What is your sentiment on Genetic Technologies Ltd?
or
Market is currently closed. Voting is open during market hours.

Genetic Technologies Ltd News

Genetic Technologies Ltd Analysis

Genetic Technologies Ltd Company Profile

Genetic Technologies Ltd Company Profile

Genetic Technologies Limited (GTG) is an Australia-based diversified molecular diagnostics company. The Company is focused on the development and commercialization of genetic risk assessment technology. The Company is engaged in providing genomics-based tests in health, wellness and serious disease through its GeneType and EasyDNA brands. GTG is focused on developing an integrated predictive genetic testing and assessment tools enabling medical practitioners and their patients to proactively manage health. The Company’s geneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. The GeneType offers integrated risk testing for a range of serious conditions. GTG offers cancer predictive testing and assessment tools for physicians. Its Polygenic Risk Scores (PRS) platform offers integrated clinical and genetic risk delivering actionable outcomes from physicians and individuals.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsNeutralNeutralNeutralNeutralStrong Sell
SummaryBuyBuyBuyBuyStrong Sell
  • why still halted
    0
    • why still halted
      0